Top Stories

Novartis withdraws Prexige in Australia

August 14, 2007

After a number of cases of serious liver damage in Australian patients taking Prexige, Novartis withdrew the drug in that country.
 

Lilly may extend grant disclosure policy globally

August 13, 2007

Eli Lilly said it is studying the feasibility of extending its grants disclosure policy globally and could do so by next year.
 

Cipla quarrels with AIDS activists on price of drug

August 10, 2007

Accusations by AIDS advocates regarding the policies of Indian drugmaker Cipla have led to a full-on dust-up between the two.
 

Moravick takes over as Ketchum healthcare head

August 14, 2007

Ketchum named Ann Moravick EVP and director, global healthcare and brand advocacy.
 

In Other News

Pipeline problems for Wyeth

August 13, 2007

Wyeths pipeline suffered a pair of setbacks Friday as the FDA rejected Wyeths schizophrenia drug bifeprunox and safety concerns led the drugmaker to stop using a developmental Hepatitis C drug in a patient study.
 

FDA eyes Nexium, Prilosec for heart risks with early communication

August 09, 2007

The Food and Drug Administration flagged potential cardiovascular risks with AstraZenecas Nexium and its predecessor, Prilosec, but said it has not yet established an increased risk and discouraged doctors and patients from discontinuing use of the drugs.
 

FDA rejects new use for GSK&s Advair

August 10, 2007

GlaxoSmithKline (GSK) said that FDA has rejected the drugmakers supplemental drug application for the 500/50 strength of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) to treat patients with chronic obstructive pulmonary disease (COPD).
 

ImClone appoints former J&J exec as CEO

August 10, 2007

ImClone Systems said Thursday that former Johnson Johnson executive John Johnson will take over as CEO effective Aug. 27.
 

Sponsored Links

Extend Your Reach with About.com Health

About.com Health delivers a robust audience of 7 million uniques each month who come for relevant health information in more than 80 in-depth topic areas. About.com Health delivers a high quality audience: a high concentration of women between the ages of 25-54 - higher than other health web sites - and an audience that goes online more frequently for health information. To reach this healthy audience, contact Michael Frick at mfrick@about.com or find out more at humanexperience.about.com.

In Other News

Key advisor: FDA should hold diabetes drugs to different standard

August 09, 2007

In an opinion piece yesterday, the chair of the FDA advisory committee on Avandia recommended the agency change the way it evaluates experimental diabetes drugs.
 

Pfizer unveils new consumer Web site

August 14, 2007

Pfizer has launched a refreshed consumer Web site at www.pfizer.com featuring a cleaner design and new features.
 

J&J sues Red Cross over use of symbol

August 09, 2007

A legal battle is under way between Johnson Johnson and the American Red Cross involving the use of the iconic red cross logo that is currently used by both organizations.
 

Nektar to team with Bayer on inhaled antibiotic

August 08, 2007

Nektar Therapeutics, co-marketer of the inhaled insulin Exubera, has inked a deal to jointly develop an inhaled antibiotic to treat pneumonia with German drugmaker Bayer.
 

Monroid takes the helm at Euro&s Metamax

August 14, 2007

Euro RSCG Life announced it has hired Cline, Davis Manns Julie Monroid to head its MetaMax unit (as first reported in the MMM Agency Issue, July 2007), which is responsible for much of its Sanofi-Aventis business.
 

Product news

August 14, 2007

InSite Vision, an ophthalmic therapeutics, diagnostics and drug delivery company, announced the US launch and commercial availability of AzaSite (azithromycin ophthalmic solution) 1% for the treatment of bacterial conjunctivitis by Inspire Pharmaceuticals.
 

People news

August 14, 2007

MAP Pharmaceuticals announced that Stephen Shrewsbury has been promoted to chief medical officer, a newly created position.
 

Company news

August 14, 2007

The FDA on Monday accused Pfizer of false advertising for its anti-schizophrenia drug Geodon, CNNMoney reported.
 



Advertise
For details on how to advertise in MM&M News Brief, please email Doreen Gates

Unsubscribe
To unsubscribe from the MM&M News Brief click here.
To manage your entire MM&M profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "email.mmm-online.com". When configuring e-mail or spam
filter rules, please use this domain name.

Medical Marketing & Media Magazine
114 W. 26th Street 4th Floor
New York N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150
http://www.mmm-online.com/

© 2013 Haymarket Media Inc.